These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2697708)

  • 1. Therapy of ocular toxoplasmosis.
    Rothova A; Buitenhuis HJ; Meenken C; Baarsma GS; Boen-Tan TN; de Jong PT; Schweitzer CM; Timmerman Z; de Vries J; Zaal MJ
    Int Ophthalmol; 1989 Dec; 13(6):415-9. PubMed ID: 2697708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy for ocular toxoplasmosis.
    Rothova A; Meenken C; Buitenhuis HJ; Brinkman CJ; Baarsma GS; Boen-Tan TN; de Jong PT; Klaassen-Broekema N; Schweitzer CM; Timmerman Z
    Am J Ophthalmol; 1993 Apr; 115(4):517-23. PubMed ID: 8470726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of ocular toxoplasmosis. Part 2: Therapeutic approaches].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 Jun; 61(4-5):154-60. PubMed ID: 8361145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis.
    Soheilian M; Sadoughi MM; Ghajarnia M; Dehghan MH; Yazdani S; Behboudi H; Anisian A; Peyman GA
    Ophthalmology; 2005 Nov; 112(11):1876-82. PubMed ID: 16171866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis.
    Opremcak EM; Scales DK; Sharpe MR
    Ophthalmology; 1992 Jun; 99(6):920-5. PubMed ID: 1630782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review.
    Iaccheri B; Fiore T; Papadaki T; Androudi S; Janjua S; Bhaila I; Stephen Foster C
    Clin Ther; 2008 Nov; 30(11):2069-74. PubMed ID: 19108794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Presumed toxoplasmic chorioretinitis: comparative study of treatment with pyrimethamine and sulfadiazine or clindamycin].
    Colin J; Harie JC
    J Fr Ophtalmol; 1989; 12(3):161-5. PubMed ID: 2695556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of treatment on the Sabin-Feldman test in ocular toxoplasmosis].
    Ziobrowski S
    Klin Oczna; 1985 Aug; 87(8):324-6. PubMed ID: 3831574
    [No Abstract]   [Full Text] [Related]  

  • 9. Current treatment of ocular toxoplasmosis in immunocompetent patients: a network meta-analysis.
    Zhang Y; Lin X; Lu F
    Acta Trop; 2018 Sep; 185():52-62. PubMed ID: 29704469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of therapy in ocular toxoplasmosis. Comparison of various forms of therapy].
    Damms T; Böhnke M; Behrend-Berdin B
    Ophthalmologe; 1993 Dec; 90(6):737-41. PubMed ID: 8124045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of clindamycin in the treatment of ocular toxoplasmosis].
    Jeddi A; Azaiez A; Bouguila H; Kaoueche M; Malouche S; Daghfous F; Ayed S
    J Fr Ophtalmol; 1997; 20(6):418-22. PubMed ID: 9296037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized trial of pyrimethamine and azithromycin vs pyrimethamine and sulfadiazine for the treatment of ocular toxoplasmosis.
    Bosch-Driessen LH; Verbraak FD; Suttorp-Schulten MS; van Ruyven RL; Klok AM; Hoyng CB; Rothova A
    Am J Ophthalmol; 2002 Jul; 134(1):34-40. PubMed ID: 12095805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of toxoplasmosis. The treatment of toxoplasmic chorioretinitis].
    Psilas K; Petroutsos G; Aspiotis M
    J Fr Ophtalmol; 1990; 13(11-12):551-3. PubMed ID: 2081846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
    HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clindamycin in the treatment of toxoplasmic retinochoroiditis.
    Lakhanpal V; Schocket SS; Nirankari VS
    Am J Ophthalmol; 1983 May; 95(5):605-13. PubMed ID: 6846454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management].
    Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P
    J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of ocular toxoplasmosis. Part 1: Basic principles and diagnosis].
    Mittelviefhaus H
    Kinderarztl Prax; 1993 May; 61(3):90-6. PubMed ID: 8326704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital toxoplasmosis with unusual retinal findings.
    Brady-McCreery KM; Hussein MA; Paysse EA
    Arch Ophthalmol; 2003 Aug; 121(8):1200-1. PubMed ID: 12912703
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fansidar in the treatment of toxoplasmosis].
    Michalová K; Ríhová E; Havlíková M
    Cesk Slov Oftalmol; 1996 Jul; 52(3):173-8. PubMed ID: 8768475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.